These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 2237773

  • 1. Adoptive immunotherapy of human pancreatic cancer with lymphokine-activated killer cells and interleukin-2 in a nude mouse model.
    Marincola FM, Da Pozzo LF, Drucker BJ, Holder WD.
    Surgery; 1990 Nov; 108(5):919-29. PubMed ID: 2237773
    [Abstract] [Full Text] [Related]

  • 2. [Effect of LAK cells and BRM on the growth of pancreatic cancer cells injected into nude mice].
    Asano H, Kobari M, Yusa T, Kawakami K, Matsuno S.
    Nihon Geka Gakkai Zasshi; 1994 Sep; 95(9):678-88. PubMed ID: 7838109
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A study to increase the therapeutic effects of adoptive immunotherapy in vivo. Influence on the generation of lymphokine activated killer (LAK) cells and therapeutic effects of LAK cells with anti-tumor drug (cyclophosphamide)].
    Yoshimori K.
    Nihon Ika Daigaku Zasshi; 1992 Oct; 59(5):418-27. PubMed ID: 1430114
    [Abstract] [Full Text] [Related]

  • 6. Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.
    Sacchi M, Snyderman CH, Heo DS, Johnson JT, d'Amico F, Herberman RB, Whiteside TL.
    Cancer Res; 1990 May 15; 50(10):3113-8. PubMed ID: 2334906
    [Abstract] [Full Text] [Related]

  • 7. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
    Saarloos MN, Khoo NK, Lala PK.
    Cancer Res; 1992 Dec 01; 52(23):6452-62. PubMed ID: 1423293
    [Abstract] [Full Text] [Related]

  • 8. The in vivo distribution of human peripheral blood lymphocytes and lymphokine-activated killer cells adoptively transferred in human pancreatic cancer-bearing nude mice.
    Marincola FM, Drucker BJ, Keeling CA, Siao DY, Starnes HF, Goodwin DA, Holder WD.
    Surgery; 1989 Jan 01; 105(1):79-85. PubMed ID: 2492121
    [Abstract] [Full Text] [Related]

  • 9. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ, Mulé JJ, Rosenberg SA.
    Cancer Res; 1986 Oct 01; 46(10):4973-8. PubMed ID: 3489517
    [Abstract] [Full Text] [Related]

  • 10. Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma.
    Thompson JA, Bianco JA, Benyunes MC, Neubauer MA, Slattery JT, Fefer A.
    Cancer Res; 1994 Jul 01; 54(13):3436-41. PubMed ID: 8012963
    [Abstract] [Full Text] [Related]

  • 11. Human lymphokine-activated killer cells augment immunotherapy of human colon carcinoma xenografts with monoclonal antibody D612.
    Pendurthi TK, Schlom J, Primus FJ.
    J Immunother (1991); 1991 Feb 01; 10(1):2-12. PubMed ID: 2012797
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the antitumor activity of human IL-4 by in vitro and in vivo assays.
    Wang T, Chen W.
    Chin Med Sci J; 1994 Dec 01; 9(4):248-54. PubMed ID: 7718866
    [Abstract] [Full Text] [Related]

  • 13. [Effects of lymphokine-activated killer cells and interleukin-2 on the ascites formation and the survival time of nude mice bearing human ovarian cancer cells].
    Kikuchi Y, Oomori K, Miyauchi M, Kita T, Kuki E, Iwano I, Hirata J, Nagata I.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec 01; 41(12):1891-5. PubMed ID: 2592812
    [Abstract] [Full Text] [Related]

  • 14. [The anti-pancreatic cancer efficacy of LAK cells mediated by YPC3 monoclonal antibody in vitro and in vivo].
    Chen QK, Yuan SZ.
    Zhonghua Zhong Liu Za Zhi; 1994 Sep 01; 16(5):353-5. PubMed ID: 7895586
    [Abstract] [Full Text] [Related]

  • 15. Ineffectiveness of adoptive chemoimmunotherapy with lymphokine-activated killer cells, interleukin-2, and cyclophosphamide on palpable intradermal murine bladder cancer.
    Lee K, O'Donnell RW, Cockett AT.
    J Biol Response Mod; 1988 Feb 01; 7(1):43-53. PubMed ID: 3259620
    [Abstract] [Full Text] [Related]

  • 16. [Effect of lymphokine-activated killer cells of head and neck tumors in vitro and in nude mice].
    Duan DS.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993 Feb 01; 28(5):281-3, 314. PubMed ID: 8192930
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.
    Stewart JA, Belinson JL, Moore AL, Dorighi JA, Grant BW, Haugh LD, Roberts JD, Albertini RJ, Branda RF.
    Cancer Res; 1990 Oct 01; 50(19):6302-10. PubMed ID: 2205379
    [Abstract] [Full Text] [Related]

  • 18. [Effect of lymphokine activated killer from umbilical blood on human ovarian cancer in nude mouse models].
    He YD, Peng ZL, Liu SL, Wang H, Pan XL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep 01; 38(5):810-2. PubMed ID: 17953364
    [Abstract] [Full Text] [Related]

  • 19. Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
    Gazit Z, Weiss DW, Shouval D, Yechezkeli M, Schirrmacher V, Notter M, Walter J, Kedar E.
    Cancer Immunol Immunother; 1992 Sep 01; 35(2):135-44. PubMed ID: 1596937
    [Abstract] [Full Text] [Related]

  • 20. Use of human leukocyte antigen-mismatched allogeneic lymphokine-activated killer cells and interleukin-2 in the adoptive immunotherapy of patients with malignancies.
    Kimoto Y.
    Hum Cell; 1992 Sep 01; 5(3):226-35. PubMed ID: 1467321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.